Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: The purpose of this study was to analyze the prevalence of long-term benzodiazepine use in older adults treated in general and neuropsychiatric practices in Germany. Methods: This study included 32,182 patients over the age of 65 years who received benzodiazepine prescriptions for the first time between January 2010 and December 2014 in general and neuropsychiatric practices in Germany. Follow up lasted until July 2016. The main outcome measure was the proportion of patients treated with benzodiazepines for >6 months. Results: The proportion of patients with benzodiazepine therapy for >6 months increased with age (65–70 years: 12.3%; 71–80 years: 15.5%; 81–90 years: 23.7%; >90 years: 31.6%) but did not differ significantly between men (15.5%) and women (17.1%). The proportion of patients who received benzodiazepines for >6 months was higher among those with sleep disorders (21.1%), depression (20.8%) and dementia (32.1%) than among those with anxiety (15.5%). By contrast, this proportion was lower among people diagnosed with adjustment disorders (7.7%) and back pain (3.8%). Conclusion: Overall, long-term use of benzodiazepines is common in older people, particularly in patients over the age of 80 and in those diagnosed with dementia, sleep disorders, or depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benzodiazepine harm: how can it be reduced?
Lader, M. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04418.x · Cited by 359
Benzodiazepines: Risks and Benefits. A Reconsideration
Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113503509 · Cited by 249 · cited 1×
“They are notably used in the treatment of anxiety, panic disorders, insomnia, and seizures, as well as to treat the symptoms of alcohol withdrawal [Donoghue and Lader, 2010; Baldwin et al. 2013; Kurko et al. 2015].”
BackgroundOffidani, E., Guidi, J., Tomba, E., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353198 · Cited by 166
Benzodiazepine dependence and its treatment with low dose flumazenil
Hood, S. D., Norman, A., Hince, D. A., Melichar, J. K., & Hulse, G. K. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12023 · Cited by 165 · cited 2×
“2013], many professionals have had major concerns about the dependency on these medications for decades [López-Muñoz et al. 2011; Hood et al. 2014].”
BackgroundUsage of benzodiazepines: A review
Donoghue, J., & Lader, M. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651500903447810 · Cited by 156 · cited 4×
“They are notably used in the treatment of anxiety, panic disorders, insomnia, and seizures, as well as to treat the symptoms of alcohol withdrawal [Donoghue and Lader, 2010; Baldwin et al. 2013; Kurko et al. 2015].”
BackgroundInfluentialEffectiveness of benzodiazepines: do they work or not?
Lader, M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.8.1189 · Cited by 63 · cited 2×
“Although it was suggested that benzodiazepines should only be prescribed for several weeks and for specific indications [Lader, 2008, 2014], these drugs are often prescribed on a long-term basis and for conditions for which better treatments are available (e.g. insomnia or anxiety syndromes) [Kapil…”
BackgroundImpairment of performance associated with long-term use of benzodiazepines
Gorenstein, C., Bernik, M. A., Pompéia, S., & Marcourakis, T. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900404 · Cited by 38
Cited by
Evrard, P., Pétein, C., Beuscart, J.-B., & Spinewine, A. (2022) · Implementation Science · doi:10.1186/s13012-022-01206-7 · Cited by 62
Panes, A., Pariente, A., Bénard-Laribière, A., Lassalle, R., Dureau-Pournin, C., Lorrain, S., Tournier, M., & Fourrier-Réglat, A. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0966-3 · Cited by 50
Landolt, S., Rosemann, T., Blozik, E., Brüngger, B., & Huber, C. A. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s290104 · Cited by 34
“7,8,35,45,46 We assume that the guidelines are very challenging to implement and insufficiently practicable in their current form.”
BackgroundResultInfluential
Metadata
- Authors
- Jacob, L., Rapp, M. A., & Kostev, K.
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2017-03-01
- Volume
- 7
- Issue
- 6-7
- Pages
- 191-200
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- OpenAlex
- W2597155422
- Cited by
- 41
- References
- 7
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.